Intended for healthcare professionals

Letters Rapid roll out of SARS-CoV-2 antibody testing

Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives

BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m2910 (Published 22 July 2020) Cite this as: BMJ 2020;370:m2910
  1. Laurence Gruer, honorary professor of public health,
  2. Raj Bhopal, emeritus professor of public health
  1. Usher Institute, University of Edinburgh, Edinburgh EH8 9AG, UK
  1. gruer.health{at}gmail.com

We have published a paper with 12 tables (in a supplementary file) with calculations of sensitivity, specificity, and the predictive power of a positive and negative test that will help people understand the concerns about the rapid roll-out of SARS-CoV-2 antibody tests expressed by Andersson and colleagues.1 With our colleagues we showed that even at high levels of specificity, an …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription